Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis

List of reports from Roots Analysis

< prev 1    3  
Biotherapeutics: Novel Formulation and Delivery Approaches Focus on Antibodies and Proteins 2015 - 2025
11/10/2015 | published by: Roots Analysis
... treatment of chronic diseases and also result in high profit margins for the drug developers. There are several therapeutic areas for which biopharmaceuticals are being investigated; these include oncology, metabolic disorders, viral infections, genetic disorders ...  |  read more...
USD 2,199
Non-Invasive Cancer Diagnostics Market 2015-2030
10/20/2015 | published by: Roots Analysis
... satisfying the unmet market need for advanced and efficient treatment interventions, cancer prevention, early detection and management is extremely important. The high cancer mortality rate is primarily due to delay in detection of the disease. ...  |  read more...
USD 2,199
T-Cell Immunotherapy Market 2015-2030
10/13/2015 | published by: Roots Analysis
... each year. Although cancer therapeutics continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. Specifically, immuno-oncology has been gradually nurtured by researchers over ...  |  read more...
USD 2,200
NASH Drugs Market 2015-2025
9/3/2015 | published by: Roots Analysis
... defined as significant steatohepatitis not caused due to alcohol, drugs, toxins, infectious agents or other identifiable exogenous causes. NASH is often accompanied with a high possibility of cirrhosis, a condition in which the liver functions ...  |  read more...
USD 2,199
ADC Contract Manufacturing Market (2nd edition), 2015-2025
8/10/2015 | published by: Roots Analysis
... be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. In-house manufacturing of ADCs is rare primarily because of the ...  |  read more...
USD 2,199
Global Biosimilars Market 2015 - 2025
7/22/2015 | published by: Roots Analysis
... are on the lookout for novel strategies that will help them attain maximum returns on investment. Derived from biological elements, biologic medications have transformed the treatment paradigm of life threatening, debilitating diseases. However, such drugs ...  |  read more...
USD 2,199
Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025
7/20/2015 | published by: Roots Analysis
... orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards immunotherapeutics, ...  |  read more...
USD 2,199
Pharmaceutical Anti-Counterfeiting Technologies Market 2015 - 2025
7/6/2015 | published by: Roots Analysis
... primarily revolves around the health of patients rather than revenue losses in the industry. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. Falsified or substandard drugs can lead to adverse reactions ...  |  read more...
USD 2,199
Prefilled Syringes Market 2015 - 2025 3rd Edition
6/29/2015 | published by: Roots Analysis
... devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. The origins of prefilled syringes can be traced back ...  |  read more...
USD 2,199
3D Cell Culture Market 2015-2025
5/28/2015 | published by: Roots Analysis
... are useful for studying the basic human molecular and cell biology metabolisms. Cell culturing was first initiated in flat plastic or glass dishes as 2D cell culturing. Since then, all the tissue engineering, stem cell, ...  |  read more...
USD 2,199
Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition)
5/25/2015 | published by: Roots Analysis
... specific ocular site. Several barriers have to be overcome for a successful ocular drug delivery. These include dilution of a drug by tears, clearance of a drug by the lymphatic system of conjunctiva and drug ...  |  read more...
USD 2,199
Blood Brain Barrier Technologies: Novel CNS Drug Delivery Approaches’
5/12/2015 | published by: Roots Analysis
... not treat the root cause. This is because of their inability to penetrate across the blood brain barrier (BBB). BBB is a highly selective permeable membrane which allows the entry of only specific molecules, across ...  |  read more...
USD 2,199
Biopharmaceutical Contract Manufacturing Market, 2015 - 2025
5/5/2015 | published by: Roots Analysis
... to serving as a cost-cutting tool, contract manufacturing provides several other advantages to biopharmaceutical companies including technical expertise, operational efficiency, regulatory support and the ability to focus on core competencies. Spanning multiple operations within the ...  |  read more...
USD 2,199
Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025
4/24/2015 | published by: Roots Analysis
... many pharmaceutical companies to improve these treatments as well as discover novel cancer therapies with minimum toxic effects. Targeted cancer therapy is an upcoming area gaining strong foothold in the industry and has already become ...  |  read more...
USD 2,199
Rare Diseases The Pharmaceutical Landscape and Opportunity Areas
3/23/2015 | published by: Roots Analysis
... ailments. However, there are certain diseases, termed as rare, that continue to remain untreated and neglected. Rare / orphan diseases, as the name suggests, are those diseases which are relatively infrequent in occurrence. Many orphan ...  |  read more...
USD 2,799
Gene Therapy Market, 2015 - 2025
2/25/2015 | published by: Roots Analysis
... or delete the genes causing a particular disease is known as gene therapy. Although gene therapy has not contributed significantly to the global pharmaceutical market yet, it is anticipated to grow at a fast pace ...  |  read more...
USD 2,199
Contract Manufacturing in Pharmaceutical Industry, 2015-2025
2/25/2015 | published by: Roots Analysis
... a network of suppliers. As such, contract manufacturing has evolved as one of the integral components of the pharmaceutical market. Started initially as a one-off activity, contract manufacturing has evolved into a dynamic business model; ...  |  read more...
USD 2,199
Oral Proteins and Peptides Market (2nd Edition), 2015 – 2025
1/27/2015 | published by: Roots Analysis
... delivery is the more preferred route. Although very convenient, there are many challenges which hinder this route of administration. These include enzymatic and pH-dependent degradation of the amino acid based drugs in the gastrointestinal tract, ...  |  read more...
USD 1,899
Subcutaneous Biologics: Products, Technologies and Delivery Systems
1/12/2015 | published by: Roots Analysis
... patient friendly format. Owing to its numerous compelling advantages, the concept has gained huge traction in recent years. The flexibility and convenience of subcutaneous administration over other routes of delivery, along with the increasing trend ...  |  read more...
USD 1,899
Oral Thin Films Market, 2015 - 2025
1/12/2015 | published by: Roots Analysis
... / films, the market has come a long way. Lower bioavailability of oral solid drugs, inconvenience of administering injections, inaccurate dosing by liquid formulations have turned the focus of pharmaceutical companies to develop novel oral ...  |  read more...
USD 1,899
Bispecific Antibody Therapeutics Market (2nd Edition), 2014-2024
12/2/2014 | published by: Roots Analysis
... the monoclonal antibody based therapies.Bispecific antibodies are artificial antibodies created by joining together two monoclonal antibodies (or parts) that target different epitopes. The resulting antibody has binding affinities for two or three different epitopes concurrently. ...  |  read more...
USD 1,899
Novel Drug Reconstitution Systems Market, 2014-2024
12/2/2014 | published by: Roots Analysis
... by various processes such as lyophilisation or spray drying; these drugs are then reformulated into liquid form by mixing with a suitable diluent at the time of administration. The overall market of drug reconstitution systems ...  |  read more...
USD 1,899
Dendritic Cell and CAR-T Therapies Market, 2014-2024
11/20/2014 | published by: Roots Analysis
... / orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards ...  |  read more...
USD 1,899
Inner Ear Diseases: Novel Drug Delivery Approaches, 2014 - 2025
11/5/2014 | published by: Roots Analysis
... in the market. The current treatment of inner ear diseases is primarily based on counselling, electric and magnetic nerve stimulations. At the same time, there is a growing off-label use of drugs for symptomatic relief. ...  |  read more...
USD 1,899
Microneedles for Transdermal and Intradermal Drug Delivery, 2014-2030
10/29/2014 | published by: Roots Analysis
... size, capable of creating transient pores across the skin by penetrating the stratum corneum layer to deliver molecules. These needles are not big enough to reach the nerve-rich regions of the skin; as a result, ...  |  read more...
USD 1,899
< prev 1    3  
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!